# MOTS-c peptide FAQ: Benefits, Safety, Dosing, and Legal Status > MOTS-c peptide FAQ: direct, cited answers on benefits, side effects, weight change, injection frequency, how it feels, legal status, and compounding access. A literature digest. Direct answers drawn from the published literature and the audited regulatory record — cited where the claim is quantitative, and honest where the human data does not exist. ## What are the potential benefits of MOTS-c? In animal and cell studies MOTS-c activates AMPK, improves insulin sensitivity, prevents diet-induced obesity, and enhances physical capacity in aged mice [1][2]. Human evidence is observational biomarker data, not interventional outcomes [4]. So the reported benefits describe research findings in their stated species, not demonstrated effects of taking MOTS-c in people. ## Are circulating MOTS-c levels a biomarker of health or aging? Circulating and tissue MOTS-c change with age and metabolic state, and in a chronic-hemodialysis cohort serum MOTS-c was independently associated with mortality and cardiovascular events, supporting interest in it as a human biomarker [9][12]. It is an association in defined groups, not proof that altering MOTS-c changes outcomes. ## What does the MOTS-c peptide do? MOTS-c is a 16-amino-acid mitochondrial-derived peptide that inhibits the folate cycle to activate AMPK and, under stress, translocates to the nucleus to regulate gene expression [1][3]. Its best-characterized effects are on glucose handling and skeletal muscle in animal models [1]. In 2024, casein kinase 2 (CK2) was identified as a direct binding target [5]. ## What are the negative side effects of MOTS-c? No completed human safety trial of exogenous MOTS-c has been published, so a human side-effect profile is not established [4]. All dosing figures come from rodent research and cannot be read as human safety data. As an unapproved research chemical, product purity and sterility also vary by supplier [4]. ## Is MOTS-c legal to buy? MOTS-c is not an FDA-approved drug and is sold only as a research chemical for laboratory use; it has no approved human indication or formulation [4]. See the [MOTS-c legal status](/legal-status) page, which also covers the FDA 503A compounding framework and MOTS-c's place on the July 2026 PCAC evaluation agenda. ## How often do you inject MOTS-c? There is no human dosing schedule. Published rodent studies used daily or thrice-weekly intraperitoneal injection — for example 15 mg/kg/day or 15 mg/kg three times weekly [2] — which is animal-model methodology, not human guidance [4]. ## Can MOTS-c cause weight gain? The animal literature reports the opposite direction of effect: MOTS-c prevented diet-induced obesity and increased adipose thermogenesis in mice [1]. There are no human data describing weight change from exogenous MOTS-c [4]. ## Is MOTS-c hard on the liver? No human hepatic-safety data exist for exogenous MOTS-c, so the question cannot be answered from the published evidence, which is preclinical and observational [4]. The literature does not characterize liver effects in people. ## What are the downsides of MOTS-c? The main downsides are evidentiary and regulatory: no completed human efficacy or safety trials, no validated human pharmacokinetics, an unregulated research-chemical supply, and anti-doping prohibition for athletes [4]. A pro-diabetogenic mitochondrial variant (m.1382A>C) also suggests effects are not uniform across populations [8]. ## Can I get MOTS-c over the counter? MOTS-c is not an approved drug or dietary supplement and is not sold over the counter as a consumer product; it is distributed only for laboratory research [4]. See the [MOTS-c legal status](/legal-status) page for the full regulatory picture. ## How long does it take for MOTS-c to kick in? No human onset timeline is established [4]. Effects in animal studies are reported over repeated dosing rather than as an immediate result [2]. There is no validated human pharmacokinetic profile to define an onset. ## Where is best to inject MOTS-c? The dominant route in published work is intraperitoneal injection in rodents [2]. There is no validated human injection site or protocol, so this describes research methodology rather than human guidance [4]. ## How does MOTS-c make you feel? There is no human subjective-effect data for exogenous MOTS-c [4]. The published evidence describes molecular, metabolic, and physical-capacity outcomes in animals [1][2], not a human experience. ## How long does MOTS-c take to work? Animal studies report metabolic and performance changes over repeated daily or thrice-weekly dosing rather than a defined onset [2]. No validated human timeline exists [4]. ## Does MOTS-c burn fat? In mice, MOTS-c prevented diet-induced obesity and increased adipose thermogenic activation [1], but these are animal-model findings. No human study demonstrates fat-burning from exogenous MOTS-c [4]. ## Can I inject MOTS-c every day? Some rodent studies used daily intraperitoneal dosing [1][2], but there is no human dosing schedule and no clinical recommendation for frequency or duration of use [4]. ## How long should you take MOTS-c? No validated human duration exists. Published regimens range from roughly one week to several weeks in animals [1][2] and are study-specific methodology, not human protocols [4]. ## Is MOTS-c bad for the liver? There is no human hepatic-safety evidence for exogenous MOTS-c; the published literature does not characterize liver effects in people [4]. The evidence base is preclinical and observational. ## What are the top peptides for muscle growth? MOTS-c is studied for muscle preservation and exercise-mimetic effects rather than muscle building in healthy subjects; the literature reports reduced atrophy signaling in animals, not hypertrophy [2][5]. This digest does not rank or recommend peptides. ## What should you not mix with peptides? No human drug-interaction studies of MOTS-c exist, so interaction guidance cannot be given; the question is unanswerable from the published evidence [4]. Any claim otherwise is not supported by the literature for this peptide. ## Is MOTS-c legal? MOTS-c is not an FDA-approved drug and is sold for research use only [4]. See the [MOTS-c legal status](/legal-status) page, which summarizes the FDA 503A framework and MOTS-c's listing on the July 2026 PCAC evaluation agenda from the audited regulatory record. ## Can you get MOTS-c from a compounding pharmacy? Compounded access to peptides is governed by the FDA 503A bulk-drug-substance framework, and MOTS-c is currently a substance under FDA evaluation rather than one on the bulks list, so that eligibility is unresolved [4]. See the [FDA 503A compounding framework](/legal-status) for the full explanation. ## What is the FDA 503A status of MOTS-c? MOTS-c is not FDA-approved, and the audited reference does not assign it a 503A category; it is named on the FDA's July 2026 PCAC agenda as a substance being considered for the 503A bulks list — a scheduled evaluation, not a listing decision [4]. See the [MOTS-c legal status](/legal-status) page. --- A pixel-clean readout of the MOTS-c record — the AMPK mechanism, the aged-mouse data, and the biomarker thread logged to source and tagged confirmed, every missing human datum flagged in plain HUD caution, with no clinic behind the screen and nothing here dispensed or sold.